Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,027,744
-
Total 13F shares
-
20,244,521
-
Share change
-
+44,782
-
Total reported value
-
$434,046,210
-
Put/Call ratio
-
298%
-
Price per share
-
$21.44
-
Number of holders
-
87
-
Value change
-
-$4,189,870
-
Number of buys
-
61
-
Number of sells
-
30
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) as of Q2 2020
As of 30 Jun 2020,
NextCure, Inc. - Common Stock (NXTC) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,244,521 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Canaan Partners X LLC, LORD, ABBETT & CO. LLC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., GREAT POINT PARTNERS LLC, ArrowMark Colorado Holdings LLC, Cormorant Asset Management, LP, and VANGUARD GROUP INC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.